About: Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Gunnar Hilmar Gislason et al published 27 June 2006 in Circulation

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в червні 2006 (uk) im Juni 2006 veröffentlichter wissenschaftlicher Artikel (de) article by Gunnar Hilmar Gislason et al published 27 June 2006 in Circulation (en)
publication date	wds:Q57260454-F039DB65-3E54-495D-9D5B-0E852ADDD5E2
publication date	2006-06-27 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57260454-B0531BB1-B430-40E3-B348-9C525A2B7A77
language of work or name	English
author name string	wds:Q57260454-51D2B236-C2D9-4B64-A9F5-A84ADC479827 wds:Q57260454-78661B77-FC5B-494C-8681-95BF63636CA9
author name string	Søren Rasmussen Mette Madsen
rdfs:label	Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction (en) Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction (nl)
skos:prefLabel	Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction (en) Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction (nl)
name	Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction (en) Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction (nl)
author	wds:Q57260454-0F7B64D3-2154-443B-8189-D23ED735CBD4 wds:Q57260454-1D5A555B-8089-4CA6-A558-E26A13988B44 wds:Q57260454-5DB16261-3C2E-49BC-AAF5-44ED9E7B7DE2 wds:Q57260454-99C19DD7-862A-4336-B706-60D775C98536 wds:Q57260454-A32BE39F-995D-4D88-B3CD-A75B91E9267A wds:Q57260454-A53C394E-BD61-46C0-8556-81CBACD0B520 wds:Q57260454-ACE9DB28-D2BB-4CFC-A98F-49B4D5E194C6 wds:Q57260454-EDA8EFF7-C345-4EBC-A265-72F258DBF97C wds:Q57260454-EE1B091C-7D4F-47D3-8E44-25AB0989B8FA
author	Christian Torp-Pedersen Lars Køber Søren Jacobsen Gunnar Hilmar Gislason Tina Ken Schramm Steen Z. Abildstrom Jens Friberg Jeppe Have Rasmussen Pernille Buch
title	wds:Q57260454-FDE607DB-4D92-4922-A673-E98917089D3C
title	Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction (en)
page(s)	wds:Q57260454-D0F4AF0A-C3B4-48BB-8E09-B5B147F80C5B
page(s)	2906-2913
instance of	wds:Q57260454-15021E29-75BE-42F3-AF9F-DFC46F722528
instance of	scholarly article
main subject	wds:Q57260454-BEB19E9D-3498-418D-9276-A93B2A529863 wds:Q57260454-E6675F2F-3662-48F5-866C-52C921CEA1FB
main subject	myocardial infarction acute myocardial infarction
PubMed ID	wds:Q57260454-9014C920-4AFB-4E77-874A-804DEC9B379A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16785336
PubMed ID	16785336
published in	wds:Q57260454-EAD7269D-63B8-42C9-8BB7-47ACF2BA0F02
published in	Circulation
issue	wds:Q57260454-1A5BF1A5-B5EA-496D-A5B2-7F65BEFED904
volume	wds:Q57260454-97CA6350-E237-4B94-8CA7-37EC12399C91
issue	25
volume	113
DOI	wds:Q57260454-1B605A28-5ED0-4673-9DCB-E8D0DDE5A306
DOI	http://dx.doi.org/10.1161/CIRCULATIONAHA.106.616219
DOI	10.1161/CIRCULATIONAHA.106.616219
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57260454
is cites work of	Acute coronary syndromes: diagnosis and management, part I wd:Q22241913 Platelets contribute to postnatal occlusion of the ductus arteriosus Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame Harmful effects of NSAIDs among patients with hypertension and coronary artery disease 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines wd:Q22242895 Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: Identification and development of mPGES-1 inhibitors: where we are at? Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Cardiovascular risk, hypertension, and NSAIDs 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors. Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data Clinical use and pharmacological properties of selective COX-2 inhibitors Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evi Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe? Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? The case-crossover study design in pharmacoepidemiology. Existing data sources for clinical epidemiology: The Western Denmark Heart Registry. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain wd:Q26829973 From prescription drug purchases to drug use periods – a second generation method (PRE2DUP). Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study Treatment with non-steroidal anti-inflammatory drugs in patients after myocardial infarction - a systematic review Cardiovascular risk, hypertension, and NSAIDs.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software